Trial intelligence / Profile preview

Pu Yang Wan Wu Tang and Pentoxifylline in Chronic Kidney Disease

NCT05387187Phase 3Unknown

Sponsor
Taipei Medical University Hospital
Start
May 2022
Primary completion
May 2022
Modality
HM (Herbal Medicine), TCM (Traditional Chinese Medicine)
Countries
1
01

Overview

A Phase 3 trial of buyang huanwu decoction in chronic kidney disease (CKD), sponsored by Taipei Medical University Hospital. Status: unknown.

02

Drugs

buyang huanwu decoction
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT05387187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05387187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call